DR.NOAH Biotech
PrivateLast Round
Series B
May 1, 2022
Total Funding Raised
$16.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DR.NOAH Biotech operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series B round in May 2022.
DR.NOAH Biotech is a biotechnology company that develops innovative drug combinations for orphan diseases using its proprietary AI-driven drug discovery platform, ARK.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DR.NOAH Biotech Comparables
Compare DR.NOAH Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healx | 87% | |
| Arontier | 85% | |
| PharmCADD Co., Ltd. | 84% |
For institutional investors. Book with your work email.
DR.NOAH Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2022 | ||||
| Strategic | Nov 1, 2020 | ||||
| Series A | Aug 12, 2020 | ||||
| Pre Seed | Dec 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DR.NOAH Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Pre Seed, Series A |
| CKD Venture Capital | Series B |
| KB Investment | Series A |
| Pathfinder H | Series B |
| L&S Venture Capital | Series B |
| LSK Investment | Pre Seed |
| Yuanta Investment | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 76% MoM.
- Aug 22, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
DR.NOAH Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DR.NOAH Biotech's valuation, stock price, and market status.
Is DR.NOAH Biotech a public or private company?
DR.NOAH Biotech is a private company.
What is the current stock price of DR.NOAH Biotech?
DR.NOAH Biotech is a private company, so its shares have no public market price. Caplight tracks DR.NOAH Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DR.NOAH Biotech worth (valuation)?
Valuation information for DR.NOAH Biotech is not publicly available.
Can I buy DR.NOAH Biotech stock?
DR.NOAH Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DR.NOAH Biotech's last funding round?
DR.NOAH Biotech's most recent funding round was Series B on May 1, 2022.
Who are the main investors in DR.NOAH Biotech?
Key investors in DR.NOAH Biotech include BNH INVESTMENT.
Will DR.NOAH Biotech IPO soon?
No public IPO plans have been announced for DR.NOAH Biotech.
How can I track DR.NOAH Biotech secondary market activity?
Caplight tracks bids, offers, and trades in DR.NOAH Biotech's shares on secondary markets.